In this episode of Meeting Mic, we bring you pearls and perspectives from the Association of Vision and Research in Ophthalmology 2026.

Jason Greenfield, MD, MBA, Alon Harris, MS, PhD, FARVO, and Yash Lahoti spoke with Healio about their study, which was designed to look at some of the unknown risk factors for glaucoma. 00:37

Next, Michael Zhu, a medical student at Duke University School of Medicine, told Healio about his presentation about retina imaging and how it may reveal links to Parkinson's disease. 06:12

And, Iris Fang-Yu Hu, MD, discusses her presentation on how using visual prompts helped improve glaucoma detection by a large language model. 08:35

Top headlines from the meetings. 09:31

Read the full coverage here:

Glaucoma, hypertension may be linked to dementia risk

Source: Greenfield J, et al. Artificial intelligence ready and exploratory atlas for diabetes insights: The association between glaucoma, hypertension, and cognitive performance. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

Imaging reveals link between inner nuclear layer thickness, Parkinson's disease

Source: Zhu M, et al. Macular retinal layer thickness in early Parkinson's disease. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

Reference images help AI model detect glaucoma

Source: Hu I, et al. Providing reference images to LLMs improves glaucoma detection from fundus photos. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

Smoking may be modifiable risk factor for myopia-related vision loss

Source: Flitcroft I, et al. Smoke gets in your eyes: Evidence that smoking is the first modifiable risk factor for myopia-related vision impairment. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

Thyroid eye disease shows long-term progression in real-world dataset

Source: Ramesh S, et al. Disease progression in thyroid eye disease: Findings from a large real-world study in the United States. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Neurology (AAN) Annual Meeting 2026.

Christopher Lock, MD, discusses key takeaways from the meeting. 00:12

Claire Delpirou Nouh, MD, highlights the meeting's major discussions and presentations. 05:27

Top headlines from the meetings. 08:42

Read the full coverage here:

Improved mortality outweighs cognitive risks in GLP-1 analog use

Source: Thorman IB, et al. Long-term risk of cognitive impairment with GLP-1 analogues in older adults with type 2 diabetes mellitus. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.

Prolonged seizures negatively impact productivity, quality of life in patients, caregivers

Source: Trinka E, et al. Loss of productivity, seizure worry, and patient and caregiver quality of life associated with prolonged seizures: Results from a global real-world point-in-time study. Presented at: American Academy of Neurology Annual Meeting; April 18-22, 2026; Chicago.

Improvements in biological age linked to lower stroke risk, healthier brains

Source: Rivier C, et al. Improvements in biological age acceleration lead to better neuroimaging, clinical and cognitive markers of brain health. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.

In this episode of Meeting Mic, we bring you pearls and perspectives from Miami Breast Cancer Conference 2026.

Paolo Tarantino, MD, PhD, discusses key takeaways from the meeting. :19

Paolo Tarantino, MD, PhD, highlights the meeting's major discussions and presentations. 3:02

Hope S. Rugo, MD, provides an overview of the inspiring and revelatory information presented at the conference. 4:41

Read the full coverage here:

https://www.healio.com/news/hematology-oncology/20260317/video-oncology-education-key-to-understanding-growing-data-in-breast-cancer-treatment

https://www.healio.com/news/hematology-oncology/20260317/video-discussions-on-her2positive-breast-cancer-treatment-may-alter-way-of-practicing

https://www.healio.com/news/hematology-oncology/20260317/video-trastuzumab-deruxtecan-in-adjuvant-setting-may-be-preferred-in-breast-cancer

https://www.healio.com/news/hematology-oncology/20260325/video-breast-cancer-conference-fuses-data-specialties-in-continuum-of-patient-care

https://www.healio.com/news/hematology-oncology/20260325/video-keynote-speaker-inspires-others-to-push-beyond-the-barriers-in-breast-cancer

In this episode of Meeting Mic, we bring you the highlights and insights from the San Antonio Breast Cancer Symposium 2025, as well as Healio's top headlines from the meeting.

Amy Comander, MD, DipABLM, FACLM, MSCP, highlights presentations at this year's meeting. :26

Jun J. Mao, MD, MSCE, discusses results from a phase 2 trial surrounding acupuncture for breast cancer. 1:50

Amanda M. Woodworth, MD, FACS, CPE, describes a digital toolkit for advancing risk-informed breast cancer screening. 4:41

Read the full coverage here:

Advancements in Breast Cancer, Lifestyle Medicine and A Preview of SABCS with Amy Comander, MD

Sentinel node biopsy pioneer to receive William L. McGuire Memorial Lecture Award

Tucatinib regimen delays disease progression in advanced HER2-positive breast cancer

Disclosures:

Comander reports no relevant financial disclosures.

Healio could not confirm financial disclosures for Mao and Woodworth at the time of publishing.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 Neuroscience Educational Institute (NEI) Annual Congress.

David W. Goodman, MD, LFAPA, discusses his presentation about ADHD in adults including diagnosis, treatment and the current challenges. :22

Katherine Dahlsgaard, PhD, ABPP, talks about her presentations on behavioral interventions for sleepy adolescents as well as the challenges physicians face in prescribing psychiatric medicines. 5:43

Kari L. Franson, PharmD, PhD, BCPP, FNAP, highlights her presentations on the current status of prescription digital therapeutics and the practice of de-prescribing psychiatric medicines. 17:28

Disclosures: Goodman reports receiving honoraria from Clinical Care Options, HCPLive, Medscape, Neuroscience Education Institute and World Federation for ADHD. Healio was unable to confirm relevant disclosures for Dahlsgaard or Franson at the time of publication.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 Gerontological Advanced Practice Nurses Association (GAPNA) Annual Conference.

Kimberly Posey, AGPCNP-BC, DNP, PhD, GS-C, discusses the purpose for the meeting, and highlights from this year's conference. :19

George Peraza-Smith, DNP, A-GNP-C, GNP-BC, GS-C, CNE, FAANP, immediate past president of GAPNA, provides an overview on popular presentations from the meeting, and goals for the future of the organization. 12:25

Disclosures: Healio was unable to confirm relevant disclosures at the time of publication.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Society of Retina Specialists annual meeting, as well as Healio's top headlines from the meeting.

Andrew G. Lee, MD, discusses when retina experts should refer patients to a neuro-ophthalmologist. 0:29

Sunir J. Garg, MD, FACS, FASRS, provides an overview of lessons learned from two complex surgical cases. 1:52

Sunir J. Garg, MD, FACS, FASRS, overviewed key findings from the Global Trends in Retina Survey. 5:16

Michael O'Rouke talks collaborating with Boehringer Ingelheim to develop extended-release therapies for ophthalmic diseases. 8:17

Jay S. Duker, MD, discusses EyePoint Pharmaceuticals' second phase 3 trial of Duravyu in patients with wet age-related macular degeneration. 11:08

Read the full coverage here:

https://www.healio.com/news/ophthalmology/20250731/andrew-g-lee-shares-neuroophthalmology-advice-for-retina-specialists

https://www.healio.com/news/ophthalmology/20250731/sunir-garg-shares-solutions-to-complex-surgical-cases

https://www.healio.com/news/ophthalmology/20250730/revana-collaborates-with-boehringer-ingelheim-to-develop-extendedrelease-therapies

https://www.healio.com/news/ophthalmology/20250807/eyepoint-completes-enrollment-in-second-phase-3-trial-of-sustainedrelease-amd-therapy

https://www.healio.com/news/ophthalmology/20250811/survey-treatment-for-recalcitrant-diabetic-macular-edema-varies-between-us-europe

Long-term benefits seen with Gore-Tex sutures for scleral fixation of IOLs

Source: Acaba-Berrocal L, et al. Long-term outcomes of pars plana vitrectomy and polytetrafluoroethylene sutured scleral-fixated intraocular lenses. Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California.

Study supports Iluvien as 'long-acting option' in diabetic macular edema

Source: Singer MA, et al. NEW DAY: Study design, study sites, patient enrollment: A study of intravitreal Iluvien (fluocinolone acetonide) implant as baseline therapy in patients with early diabetic macular edema (DME) (NEW DAY). Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California.

Disclosures:

Duker reports being president and CEO of EyePoint Pharmaceuticals.

Garg reports no relevant financial disclosures.

Lee reports no relevant financial disclosures.

O'Rourke reports being CEO of Re-Vana Therapeutics.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 ASCO Annual Meeting, as well as Healio's top headlines from the meeting.

Chinmay Jani, MD, discusses findings highlighting how alcohol-related cancer mortality has risen sharply over the past few decades. :19

Rachel I. Vogel, PhD, provides and overview on factors contributing to the time burden cancer care places on patients. 3:02

Alexander D. Sherry, MD, discusses how improvements in OS or quality of life after phase 3 oncology trials are based on improvements in unvalidated alternative endpoints. 4:41

Lucas A. Mavromatis, ScB, discusses findings on how GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes. 7:20

Sonali M. Smith, MD, talks with Oncology Overdrive host Shikha Jain, MD, about presentations on lymphoma at this year's ASCO meeting. 9:57

Read the full coverage here:

https://www.healio.com/news/hematology-oncology/20250531/study-reveals-shocking-rise-in-alcoholrelated-cancer-deaths

https://www.healio.com/news/hematology-oncology/20250603/time-burden-people-with-cancer-face-often-vastly-underestimated

https://www.healio.com/news/hematology-oncology/20250604/few-phase-3-oncology-trials-demonstrate-improvements-in-os-quality-of-life

https://www.healio.com/news/hematology-oncology/20250522/glp1-receptor-agonists-confer-modest-protection-against-obesityrelated-cancers

https://www.healio.com/news/hematology-oncology/podcasts/oncology-overdrive/episode-119

Exercise described as 'novel, first-in-class' colon cancer therapy

Source: Booth CM, et al. Abstract LBA3510. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago.

At-home intervention has potential to enhance cancer care delivery, outcomes

Source: Nipp RD, et al. Abstract 11003. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago.

Disclosures:

Jani reports no relevant financial disclosures.

Mavromatis reports no relevant financial disclosures.

Sherry reports honoraria from Sermo.

Smith reports no relevant financial disclosures.

Vogel reports a consulting/advisory role with Voluntis.